HOME >> MEDICINE >> NEWS
Men more at risk of recurrent blood clots than women

Men have a 50% higher relative risk of suffering from recurrent blood clots after a first episode than women, according to an article in this week's issue of The Lancet. The baseline frequency of recurrent blood clots is 25% after five years.

Dr Simon McRae from the Department of Haematology (Queen Elizabeth Hospital, Woodville, South Australia, Australia) and his colleagues from the Department of Medicine, McMaster University (Hamilton, Ontario, Canada) did a meta-analysis of studies involving both men and women who were being treated for either deep vein thrombosis or pulmonary embolism (in which a clot detaches from a deep vein and lodges in the lung). They looked at rates of recurrence of blood clots in patients after they had stopped taking preventative anticoagulant (blood-thinning) medication.

A total of 5416 patients were enrolled in 15 eligible studies, 50% were men and 50% women. There were 816 recurrent blood clots, of which 523 (64%) were in men and 293 (36%) were in women.

The cause of heightened risk in men is unclear, but the authors state it could be attributable to differences in age, body mass index, or inherited susceptibility to blood clots. Dr Simon McRae writes: "further prospective studies are needed before a firm recommendation can be made to incorporate patient sex into decision making on duration of anticoagulant treatment in individual patients."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
27-Jul-2006


Page: 1

Related medicine news :

1. Vorinostat shows anti-cancer activity in recurrent gliomas
2. New class of targeted cancer drugs shows promise in slowing progression of recurrent prostate cancer
3. Popular statin reduces recurrent stroke risk
4. Measurement of urinary protein can help detect recurrent bladder cancer
5. Point-of-care test proves more effective for recurrent bladder cancer than conventional lab test
6. Antibiotics do not prevent recurrent myocardial infarcts in subjects with periodontitis
7. Study suggests mechanism for recurrent sudden infant death syndrome
8. Biomarkers may provide important information for patients at risk for recurrent ischemic stroke
9. Treatment regimen offers greater survival advantage for recurrent head and neck cancers
10. Biomarkers used to predict recurrent disease in hepatitis C transplant patients
11. Antidepressants may lower risk of recurrent heart attack in depressed heart attack patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... ... Pullano Law Offices, a Chicago personal injury law firm, is pleased to ... as President of the North Suburban Bar Association for 2017-2018. Mr. Pullano was installed ... NSBA at the North Shore Country Club in Glenview, IL, on September 13, 2017. ...
(Date:9/22/2017)... ... 22, 2017 , ... Silicon Valley startup Enke Life has ... Their electric toothbrushes aggressively attack oral bacteria by reducing dental plaque and other ... edge Enke technology with a premium timeless design, they want to redefine the ...
(Date:9/22/2017)... Connecticut (PRWEB) , ... September 22, 2017 , ... ... conquering Lyme and other tick-borne diseases through research, education and awareness, today announced ... , A noted immunologist and microbiologist, Dr. Sellati has more than 20 years ...
(Date:9/21/2017)... Los Angeles, CA (PRWEB) , ... September 21, ... ... co-hosting a lunch and learn with Infinity Behavioral Health Services for professionals in ... Know in a Commercial Payer Audit . , Insurance companies and state ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... right or exercise more try taking a more holistic approach and use natural ... new Amazon essential oil collection is certified USDA guaranteeing that, the new line ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... ... ... – Monday, September 18 th .The Brain Tumor Foundation (BTF) begins ... the public.Where:  BTF,s Mobile MRI Unit – a ... Washington, D.C.What:BTF brings its nationwide initiative, the Road to Early Detection Sponsor-A-City ...
(Date:9/9/2017)... Lilly and Company (NYSE: LLY ) will ... an investigational, oral, first-in-class molecule for the acute treatment ... placebo in the Phase 3 SPARTAN study. Detailed results ... the International Headache Society (IHC) in Vancouver ... lasmiditan,s potential to reduce pain and provide freedom from ...
(Date:9/7/2017)... MIRAGE, Calif. , Sept. 7, 2017  For nearly two decades, ... service in the Assisted Reproduction Insurance industry. Today, New Life Agency announces ... fertility medications. ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ... ...
Breaking Medicine Technology:
Cached News: